The DOI matches its Crossref record; 94 of the 98 references it cites were found in a registry or an index.
Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis
Abstract
OBJECTIVE: We aimed to estimate pooled percentages of patients with adrenal insufficiency after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we aimed to stratify the results by route of administration, disease, treatment dose, and duration. METHODS: We searched seven electronic databases (PubMed, MEDLINE, EMBASE, COCHRANE, CENTRAL, Web of Science, and CINAHL/Academic Search Premier) in February 2014 to identify potentially relevant studies. Original articles testing adult corticosteroid users for adrenal insufficiency were eligible. RESULTS: We included 74 articles with a total of 3753 participants. Stratified by administration form, percentages of patients with adrenal insufficiency ranged from 4.2% for nasal administration (95% confidence interval [CI], 0.5-28.9) to 52.2% for intra-articular administration (95% CI, 40.5-63.6). Stratified by disease, percentages ranged from 6.8% for asthma with inhalation corticosteroids only (95% CI, 3.8-12.0) to 60.0% for hematological malignancies (95% CI, 38.0-78.6). The risk also varied according to dose from 2.4% (95% CI, 0.6-9.3) (low dose) to 21.5% (95% CI, 12.0-35.5) (high dose), and according to treatment duration from 1.4% (95% CI, 0.3-7.4) (<28 d) to 27.4% (95% CI, 17.7-39.8) (>1 year) in asthma patients. CONCLUSIONS: 1) Adrenal insufficiency after discontinuation of glucocorticoid occurs frequently; 2) there is no administration form, dosing, treatment duration, or underlying disease for which adrenal insufficiency can be excluded with certainty, although higher dose and longer use give the highest risk; 3) the threshold to test corticosteroid users for adrenal insufficiency should be low in clinical practice, especially for those patients with nonspecific symptoms after cessation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk also varied when stratified for the underlying disease and increased with higher dose (low dose 2.4% (95% CI 0.6-9.3) to high dose 21.5% (95% CI 12.0-35.5)) and longer treatment duration (1.4% (95% CI 0.3-7.4) (<28 days) to 27.4% (95% CI 17.7-39.8) (>1 year)) in patients with asthma.”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“A meta-analysis of the risk of developing biochemical glucocorticoid-induced adrenal insufficiency stratified by glucocorticoid route of administration showed pooled percentages of 4.2% (95% CI 0.5-28.9) for nasal administration, 48.7% (95% CI 36.9-60.6) for oral use, and 52.2% (95% CI 40.5-63.6) for intra-articular administration (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Of these 521 patients, 98 patients had biochemical evidence of adrenal insufficiency. Ten of them (10%) reported symptoms. However, 88 (90%) did not report any symptoms”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“In the above-mentioned meta-analysis, ten of the 74 included studies also assessed symptoms of adrenal insufficiency (although not systematically scored) in a total of 521 patients (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Broersen et al performed a meta-analysis on eleven out of seventeen studies re-testing patients for biochemical adrenal insufficiency for which results could be categorized in short-term (defined as less than 4 weeks) high-dose glucocorticoid therapy re-testing after 4 weeks (six studies), and long-term (>1 year) medium-dose glucocorticoid therapy re-testing after 6 months (five studies) (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
Distinguishing Case Series From Cohort Studies
Dekkers, O. M., Egger, M., Altman, D. G., & Vandenbroucke, J. P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-1-201201030-00006 · Cited by 308
Self-citationSuppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X. H., & Briner, V. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06290-x · Cited by 290
Greenberg, G., Feagan, B., Martin, F., Sutherland, L., Thomson, A., Williams, C., Nilsson, L., & Persson, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536887 · Cited by 288
Research works printed but not linked: 1
- Ruiz Munoz, 1988, Adrenocortical function and steroid doses in renal transplant patients, Dial Transplant, 17, 184
Cited by
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30024-3 · Cited by 1,370
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
Rhinitis 2020: A practice parameter update
Dykewicz, M. S., Wallace, D. V., Amrol, D. J., Baroody, F. M., Bernstein, J. A., Craig, T. J., Dinakar, C., Ellis, A. K., Finegold, I., Golden, D. B. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.007 · Cited by 436
Endocrine toxicities of immune checkpoint inhibitors
Wright, J. J., Powers, A. C., & Johnson, D. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00484-3 · Cited by 441
Metadata
- Authors
- Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Aarhus University (DK)
- Corresponding author
- Dekkers, Olaf M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-06-01
- Volume
- 100
- Issue
- 6
- Pages
- 2171-2180
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022140603
- Cited by
- 456
- References
- 98
- Citations by year
- 2026: 39 · 2025: 53 · 2024: 50 · 2023: 55 · 2022: 52 · 2021: 48 · 2020: 53 · 2019: 39 · 2018: 28 · 2017: 20 · 2016: 14 · 2015: 5
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Novo Nordisk Fonden (NNF-13OC0007869)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal insufficiency, glucocorticoid-induced adrenal insufficiency, corticosteroid use, glucocorticoid dose, treatment duration, route of administration, intra-articular corticosteroids, inhaled corticosteroids, asthma, hematologic malignancies, adrenal function testing
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Insufficiency, Adult, Dosage Forms, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Administration Schedule, Humans, Inflammation, Neoplasms, Skin Diseases, Organ Transplantation, Transplantation Conditioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1210/jc.2015-1218
- The paper
- Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M. (2015). Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2015-1218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.